40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
54.43%
Positive revenue growth while MTDR is negative. John Neff might see a notable competitive edge here.
5.28%
Positive gross profit growth while MTDR is negative. John Neff would see a clear operational edge over the competitor.
492.56%
Positive EBIT growth while MTDR is negative. John Neff might see a substantial edge in operational management.
492.56%
Positive operating income growth while MTDR is negative. John Neff might view this as a competitive edge in operations.
557.39%
Positive net income growth while MTDR is negative. John Neff might see a big relative performance advantage.
411.11%
Positive EPS growth while MTDR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
423.22%
Positive diluted EPS growth while MTDR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
26.55%
Slight or no buybacks while MTDR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
25.33%
Slight or no buyback while MTDR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-18.60%
Dividend reduction while MTDR stands at 0.08%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
21.05%
Positive OCF growth while MTDR is negative. John Neff would see this as a clear operational advantage vs. the competitor.
517.03%
Positive FCF growth while MTDR is negative. John Neff would see a strong competitive edge in net cash generation.
89.23%
10Y revenue/share CAGR under 50% of MTDR's 690.14%. Michael Burry would suspect a lasting competitive disadvantage.
89.23%
5Y revenue/share CAGR under 50% of MTDR's 1272.50%. Michael Burry would suspect a significant competitive gap or product weakness.
89.23%
Positive 3Y CAGR while MTDR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
116.56%
10Y OCF/share CAGR under 50% of MTDR's 1566.28%. Michael Burry would worry about a persistent underperformance in cash creation.
116.56%
Below 50% of MTDR's 362.73%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
116.56%
Positive 3Y OCF/share CAGR while MTDR is negative. John Neff might see a big short-term edge in operational efficiency.
2174.66%
Net income/share CAGR above 1.5x MTDR's 163.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2174.66%
5Y net income/share CAGR above 1.5x MTDR's 139.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2174.66%
Positive short-term CAGR while MTDR is negative. John Neff would see a clear advantage in near-term profit trajectory.
147.31%
10Y equity/share CAGR at 50-75% of MTDR's 274.37%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
147.31%
5Y equity/share CAGR at 50-75% of MTDR's 204.54%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
147.31%
3Y equity/share CAGR 1.25-1.5x MTDR's 101.40%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
108.99%
Dividend/share CAGR of 108.99% while MTDR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
108.99%
Dividend/share CAGR of 108.99% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
108.99%
Below 50% of MTDR's 529.33%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-8.04%
Firm’s AR is declining while MTDR shows 2.38%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-26.64%
Inventory is declining while MTDR stands at 23.07%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.30%
Asset growth above 1.5x MTDR's 1.79%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-6.34%
We have a declining book value while MTDR shows 2.09%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-7.55%
We’re deleveraging while MTDR stands at 0.54%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-320.40%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.